Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension

This study has been completed.
Information provided by:
Pfizer Identifier:
First received: June 20, 2011
Last updated: June 21, 2011
Last verified: June 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2003
  Primary Completion Date: March 2003 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):